AzTrials
AzTrials

Autism Spectrum DisorderNCT04980963

Cognitive Support Technology for Postsecondary Students With Autism Spectrum Disorder

A study testing Cognitive Support Technology (CST) in people with Autism Spectrum Disorder, run by Kent State University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will fill important knowledge gaps in the availability of best practices that use innovative methods to integrate the cognitive and vocational needs of students with Autism Spectrum Disorder (ASD) who will be transitioning from 2- and 4-year postsecondary education to employment. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Cognitive Support Technology (CST)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteUnited States
Study dates
1 Mar 2020to 30 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Must be a post-secondary student enrolled in degree programs at two-year and four-year colleges or universities within a 60-mile radius of Kent, Ohio
  • Must have a clinical diagnosis of Autism Spectrum Disorder

Who cannot join

  • No other exclusion criteria will be applied

Trial locations and contacts

1 site in 1 country.

Mykal Leslie, PhD contact

3306725798

mleslie8@kent.edu

Phillip Rumrill, PhD contact

3306720600

prumrill@kent.edu

United States1 site, 1 recruiting
  • Kent State University

    Kent, Ohio, 44242-0001

    Mykal J Leslie, PhD, 330-672-5798, mleslie8@kent.edu

    Phillip Rumrill, PhD, 3306720600, prumrill@kent.edu

    Recruiting

Other trials in United States

About this study

Official title: Cognitive Support Technology for Postsecondary Students With Autism Spectrum Disorder: A Randomized Clinical Trial at the Intervention Efficacy Stage of Research

This study will fill important knowledge gaps in the availability of best practices that use innovative methods to integrate the cognitive and vocational needs of students with Autism Spectrum Disorder (ASD) who will be transitioning from 2- and 4-year postsecondary education to employment. Best practices exist from the assistive technology (AT) field to help people compensate for cognitive impairments, and from the vocational rehabilitation (VR) field to enhance employment outcomes for individuals with disabilities. However, these practices have not been integrated to provide needed supports and services to improve the employment outcomes of students with ASD. The study's goal is to expand the availability of innovative practices by testing the efficacy of a technology-driven, long-term, and resource-rich individualized support program that merges assistive technology for cognition and vocational rehabilitation practices. The end products will include technology application guidelines, training and procedural manuals, and resource information that rehabilitation professionals and students with ADS can utilize to enhance technology and mentoring proficiency, academic success, self-determination, and long-term career success for students with ASD.

The knowledge to be gained from this research will have a beneficial impact on students with ASD, rehabilitation professionals, higher education personnel, case managers, and employers who work with people with ASD. There is strong potential for the students to develop skills that will help them succeed in learning as well as employment settings. The ultimate benefit of research activities for the target population will be seen in the improved capacity for postsecondary students with ADS to utilize state-of-the-art technology to accommodate disability-related limitations, address career readiness, and to prepare for and obtain employment after graduation.

Because the risks to subjects are no greater than those associated with everyday life and because the study staff will refer students who are in psychological distress or medical emergency situations to appropriate resources in the community, the minimal risks of this study justify the considerable benefits that this study will yield. Not only will the study benefit participating students, it stands to make important contributions to the knowledge bases in the fields of assistive technology and rehabilitation.

Being tested
Cognitive Support Technology (CST)
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Support Technology (CST)Behavioural

    Cognitive Support Technology (CST) products and strategies are used to help people with disabilities compensate for or accommodate cognitive limitations (including those related to interpersonal communication and social cognition) that present difficulties for them in the performance of desired social roles, especially education and employment. CSTs may be mainstream everyday technologies such as tablet computers or they may be specialized devices designed for specific goals such as step-by-step instruction in the performance of a particular task (Scherer, 2012).

Study groups in NCT04980963
Study groupRoleWhat they receive
Full TreatmentExperimentalSteps of the Intervention Condition. Following an in-person session in which a pretest assessment is completed, each member of the intervention group will participate in three face-to-face sessions with the interventionist at the student's campus or at the interventionist's office to complete the CST component of the intervention. Taking into consideration available psychoeducational assessment data, functional assessments from other agencies, and the participant's self-report regarding the functional difficulties that result from his or her ASD-related cognitive impairments, Scherer's (2012) Matching Person and Technology (MPT) protocol will guide the CST assessment. For purposes of the CST component of this intervention, the technological platform for cognitive accommodations will be an iPad II that is provided to each intervention-group participant at no charge (including wireless access if needed). The interventionist will provide training in the use of the iPad if necessary.
Receives: Behavioral: Cognitive Support Technology (CST)
Abbreviated TreatmentActive comparatorSteps of the Control Condition. Following an in-person session in which the pretest assessment is completed, each member of the control group will participate in two telephone or Skype sessions with the interventionist to discuss her or his needs for electronic cognitive supports. An abbreviated version of Scherer's (2012) MPT assessment will be administered via telephone or Skype in the first of these virtually-administered sessions. In the second telephone or Skype session, the interventionist will summarize the results of the abbreviated MPT assessment, suggest a variety of cognitive enhancement apps for tablet computers or smart phones that the control group participant can consider.
Receives: Behavioral: Cognitive Support Technology (CST)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Grade Point Average (GPA)

    Participant GPA

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

Secondary outcomes (11)
  1. Current academic standing

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  2. Post-Secondary Enrollment Status

    % of participants still enrolled in a postsecondary program

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  3. Satisfaction with current living status and transportation access

    Measured using single item 5-point Likert question on questionnaire

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  4. Satisfaction with Social Support

    Measured using single item 5-point Likert question on questionnaire

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  5. Current Employment Status

    Three items on questionnaire including dichotomous employment question (e.g., are you employed?), if yes, number of hours employed and weekly earnings.

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  6. % of Participants Receiving Disability Benefits

    Whether participants receive SSDI and/or SSI benefits or not

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  7. Depression Symptoms

    Measured using Beck Depression Inventory- II (BDI-II)

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  8. Overall Health Status

    Measured using RAND 36-item Health Survey

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  9. Perceived Stress

    Measured using Perceived Stress Scale- 10

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  10. Acceptance of Disability

    Measured using the Acceptance of Disability Scale- Short Form

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

  11. Quality of Life (QoL)

    Measured using the Qualify of Life Scale

    Measured: Baseline (enrollment in study), 6 months, and 1 year (study completion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2021
  2. Study start1 Mar 2020
  3. Primary completion30 Jun 2024 (estimated)
  4. Study completion30 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
A minimum total of 90 students will be recruited for the study. Study personnel will recruit 30 students in each of years 2, 3, and 4. Of the 30 students per year, 15 will be randomly assigned to the full treatment intervention and 15 students will be randomly assigned to the control group. Participants will range in age from approximately 18 years to 25 years, but all ages are welcome to participate. The selection of the target population for this research study is based on the bleak employment outcomes of students with ASD compared to students without disabilities. In addition, it is based on the lack of practices that integrate the cognitive and vocational needs of students with ASD who are pursuing postsecondary education to help them successfully complete academic requirements, address career development, enhance career readiness skills, and obtain and maintain employment.
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04980963
Sponsor's protocol ID
20-069
Status last verified
Jul 2021
First submitted
17 Sep 2020
Last updated
28 Jul 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Support Technology (CST) in people with Autism Spectrum Disorder, run by Kent State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mykal Leslie, PhD (3306725798, mleslie8@kent.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Grade Point Average (GPA) (time frame: Baseline (enrollment in study), 6 months, and 1 year (study completion)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in